• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Poll garners patient, prescriber opinions on AK treatments

Article

New Orleans - Patients and physicians express various levels of satisfaction and dissatisfaction with the most common treatment modalities for actinic keratoses. Both groups have strong interest as well in newer therapies, according to the results of a survey presented by James Q. Del Rosso, D.O., at the annual meeting of the American Academy of Dermatology.

Related Videos
Related Content
Social Media’s Influence on Consumers, TrenibotulinumtoxinE, and More From the SEASON Aesthetic Conference

Social Media’s Influence on Consumers, TrenibotulinumtoxinE, and More From the SEASON Aesthetic Conference

Article
The Cutaneous Connection: A Reminder of Patient Impact

The Cutaneous Connection: A Reminder of Patient Impact

Podcast
Topical Antibiotic Treatment Significantly Reduced Depigmentation in Mouse Model

Topical Antibiotic Treatment Significantly Reduced Depigmentation in Mouse Model

Article
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment

The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment

Podcast
Insights Into Clear Health’s Low-Dose Microdose Accutane Protocol For Mild Acne

Insights Into Clear Health’s Low-Dose Microdose Accutane Protocol For Mild Acne

Article
2 Years of Treatment With Dupilumab Led to Improvements In Symptoms of AD and Comorbid Anxiety, Depression

2 Years of Treatment With Dupilumab Led to Improvements In Symptoms of AD and Comorbid Anxiety, Depression

Article
© 2024 MJH Life Sciences

All rights reserved.